We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

3 hedge funds and large institutions have $7.74M invested in Altamira Therapeutics Ltd in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% less funds holding

Funds holding: 10 → 3 (-7)

79% less capital invested

Capital invested by funds: $37.1M → $7.74M (-$29.3M)

80% less call options, than puts

Call options by funds: $10K | Put options by funds: $50K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-7
Holders Change %
-70%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
7
Calls
$10K
Puts
$50K
Net Calls
-$40K
Net Calls Change
-$44K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.47M
2
WA
Wasatch Advisors
Utah
-$4.29M
3
RSCM
Rock Springs Capital Management
Maryland
-$3.56M
4
OM
Opaleye Management
Massachusetts
-$1.43M
5
TAM
Tocqueville Asset Management
New York
-$314K
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Bellevue Group
Switzerland
$3.75M – – –
WA
2
Wasatch Advisors
Utah
$2.38M -$4.29M -18 -51%
TCM
3
Tekla Capital Management
Massachusetts
$1.34M – – –
VKH
4
Virtu KCG Holdings
New York
$46K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$44K – – –
KeyBank National Association
6
KeyBank National Association
Ohio
$41K -$238K -1 Closed
CG
7
Cutler Group
California
$34K – – –
WS
8
Wedbush Securities
California
$30K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$27K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$18K – – –
SPC
11
Sigma Planning Corp
Michigan
$18K – – –
Citigroup
12
Citigroup
New York
$3K – – –
Group One Trading
13
Group One Trading
Illinois
$3K – – –
ASN
14
Advisory Services Network
Georgia
$2K – – –
AIM
15
Acrospire Investment Management
Illinois
$1K – – –
Morgan Stanley
16
Morgan Stanley
New York
$1K – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
– -$6.47M -19 Closed
RSCM
18
Rock Springs Capital Management
Maryland
– -$3.56M -11 Closed
OM
19
Opaleye Management
Massachusetts
– -$1.43M -4 Closed
AG
20
Advisor Group
Arizona
– -$277K -1 Closed
FO
21
FT Options
Illinois
– -$205K -1 Closed
TAM
22
Tocqueville Asset Management
New York
– -$314K -1 Closed
AC
23
Amici Capital
New York
– -$42K – –
HCM
24
Harvey Capital Management
Florida
– -$136K – –
TC
25
TFS Capital
Pennsylvania
– -$160K – –
1
2

CYTO Hedge Fund Activity: Q3 2016 in Review

3 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2016, worth a combined $7.74M — down 79% from $37.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CYTO and 0 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $6.47M sold.

  • 3 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2016, down from 10 in Q2 2016.
  • Funds reported $7.74M of Altamira Therapeutics Ltd stock for Q3 2016, down 79% quarter-over-quarter.
  • 0 funds opened new Altamira Therapeutics Ltd positions in Q3 2016 and 7 closed out, a net change of -7 holders.
  • The largest Altamira Therapeutics Ltd seller in Q3 2016 was Fidelity Investments, an estimated $6.47M sold.

Based on aggregated 13F filings for Q3 2016.